EPIX Pharmaceuticals, Inc. Announces Retirement of Christopher Gabrieli as Chairman of the Board of Directors

LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) today announced that its Chairman of the Board of Directors, Christopher F. O. Gabrieli, has decided to retire from the EPIX Board of Directors, effective as of the date of the EPIX Annual Meeting of Stockholders on June 27, 2007. Mr. Gabrieli is a Senior Partner of Bessemer Venture Partners, and co-founder and Chairman of Massachusetts 2020, a non-profit public policy organization. As an early investor in EPIX, Mr. Gabrieli has been an active supporter and has provided the company with invaluable counsel over the years. Upon Mr. Gabrieli’s retirement, Frederick Frank, currently a member of the EPIX Board, has been appointed to serve as Chairman of the EPIX Board of Directors. Mr. Frank is also Vice Chairman and Director of Lehman Brothers, Inc.
MORE ON THIS TOPIC